Organisation paid for research Program year 2025 Source: CMS Open Payments

Clearview Cancer Institute Admin

Neither a doctor nor a teaching hospital

Research payments

$5,137

9 payments

Through program year 2025, Clearview Cancer Institute Admin is reported as receiving $5,137 in research payments, across 9 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $1,300 7
2024 Research $3,838 2

Breakdown

Who paid Research payments · program years 2024–2025
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $3,694 8 payments
  2. Boehringer Ingelheim International GmbH $1,443 1 payment
Studies the money was for Research payments · program years 2024–2025
  1. Phase 3 First line in NSCLC $3,838 2 payments
  2. Beamion LUNG-2: A Phase III, open-label, randomised, active-controlled, multi-centre trial evaluating orally administered BI 1810631 compared to standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations $1,300 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record